MenB Vaccine (Vaccine Industrial Holding)

MenB Vaccine is a vaccine targeting *Neisseria meningitidis* serogroup B, currently part of the product pipeline for Vaccine Industrial Holding (VIC), a Saudi Arabian biomanufacturing company. The vaccine is intended for the prevention of meningococcal disease caused by serogroup B strains. VIC's involvement focuses on the localization of vaccine manufacturing within Saudi Arabia, often through strategic partnerships and technology transfer to ensure national health security. The vaccine functions by inducing an active immune response against the bacteria, thereby providing protection against invasive meningococcal infections such as meningitis and septicemia.

Other names

meningococcal B vaccineMenB vaccineNeisseria meningitidis serogroup B vaccine